Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Hepatitis C

  Free Subscription

Articles published in Scand J Gastroenterol

Retrieve available abstracts of 6 articles:
HTML format

Single Articles

    June 2021
  1. WALDENSTROM J, Hellstrand K, Westin J, Nilsson S, et al
    Presence of interferon-lambda 4, male gender, absent/mild steatosis and low viral load augment antibody levels to hepatitis C virus.
    Scand J Gastroenterol. 2021 Jun 2:1-6. doi: 10.1080/00365521.2021.1922750.
    PubMed     Abstract available

    May 2021
  2. WALDENSTROM J, Kaberg M, Alanko Blome M, Widell A, et al
    Absence of interferon-lambda 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection.
    Scand J Gastroenterol. 2021 May 25:1-7. doi: 10.1080/00365521.2021.1925956.
    PubMed     Abstract available

  3. PIECHA F, Ganssler JM, Ozga AK, Wehmeyer MH, et al
    Evolution of liver stiffness and post-treatment surveillance by liver elastography for HCV patients in the DAA era.
    Scand J Gastroenterol. 2021 May 19:1-9. doi: 10.1080/00365521.2021.1915374.
    PubMed     Abstract available

    March 2021
  4. STOY S, Terczynska-Dyla E, Veidal SS, Rigbolt K, et al
    Interferon lambda 4 genotype and pathway in alcoholic hepatitis.
    Scand J Gastroenterol. 2021;56:304-311.
    PubMed     Abstract available

    July 2020
  5. ALDURAYWISH A, Ragheb M, Taher I, Louis N, et al
    Prevalence, risk factors and impact of occult HCV infection on liver morbidity among haemodialysis patients: hospital-based cross-sectional study.
    Scand J Gastroenterol. 2020 Jul 10:1-7. doi: 10.1080/00365521.2020.1790649.
    PubMed     Abstract available

    May 2020
  6. KABERG M, Larsson SB, Jerkeman A, Nystedt A, et al
    High risk of non-alcoholic liver disease mortality in patients with chronic hepatitis C with illicit substance use disorder.
    Scand J Gastroenterol. 2020 May 1:1-7. doi: 10.1080/00365521.2020.1754456.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.